Detalles de la búsqueda
1.
Mucosal Healing and Long-term Outcomes of Patients With Inflammatory Bowel Diseases Receiving Clinic-Based vs Trough Concentration-Based Dosing of Infliximab.
Clin Gastroenterol Hepatol
; 16(8): 1276-1283.e1, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29203225
2.
Evidence to Support Monitoring of Vedolizumab Trough Concentrations in Patients With Inflammatory Bowel Diseases.
Clin Gastroenterol Hepatol
; 16(12): 1937-1946.e8, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29704680
3.
Characteristics of Skin Lesions Associated With Anti-Tumor Necrosis Factor Therapy in Patients With Inflammatory Bowel Disease: A Cohort Study.
Ann Intern Med
; 164(1): 10-22, 2016 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-26641955
4.
A panel to predict long-term outcome of infliximab therapy for patients with ulcerative colitis.
Clin Gastroenterol Hepatol
; 13(3): 531-8, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25117777
5.
Switch to adalimumab in patients with Crohn's disease controlled by maintenance infliximab: prospective randomised SWITCH trial.
Gut
; 61(2): 229-34, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21948942
6.
Screening Failure in a Large Clinical Trial Centre for Inflammatory Bowel Diseases: Rates, Causes, and Outcomes.
Inflamm Bowel Dis
; 29(9): 1440-1445, 2023 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36350998
7.
Levels of C-reactive protein are associated with response to infliximab therapy in patients with Crohn's disease.
Clin Gastroenterol Hepatol
; 9(5): 421-7.e1, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21334460
8.
Tolerability of shortened infliximab infusion times in patients with inflammatory bowel diseases: a single-center cohort study.
Am J Gastroenterol
; 106(4): 778-85, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21407184
9.
Influence of trough serum levels and immunogenicity on long-term outcome of adalimumab therapy in Crohn's disease.
Gastroenterology
; 137(5): 1628-40, 2009 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-19664627
10.
Influence of Drug Exposure on Vedolizumab-Induced Endoscopic Remission in Anti-Tumour Necrosis Factor [TNF] Naïve and Anti-TNF Exposed IBD Patients.
J Crohns Colitis
; 14(3): 332-341, 2020 Mar 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-31504343
11.
Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn's disease: a controlled randomized trial.
Gastroenterology
; 135(4): 1123-9, 2008 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-18727929
12.
Withdrawal of immunosuppression in Crohn's disease treated with scheduled infliximab maintenance: a randomized trial.
Gastroenterology
; 134(7): 1861-8, 2008 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-18440315
13.
Ustekinumab Exposure-outcome Analysis in Crohn's Disease Only in Part Explains Limited Endoscopic Remission Rates.
J Crohns Colitis
; 13(7): 864-872, 2019 Jul 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-30715258
14.
Long-term Clinical Effectiveness of Ustekinumab in Patients with Crohn's Disease Who Failed Biologic Therapies: A National Cohort Study.
J Crohns Colitis
; 13(11): 1401-1409, 2019 Oct 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-30989232
15.
Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease.
N Engl J Med
; 353(4): 362-8, 2005 Jul 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-15947080
16.
Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease.
N Engl J Med
; 348(7): 601-8, 2003 Feb 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-12584368
17.
Predictors of early response to infliximab in patients with ulcerative colitis.
Inflamm Bowel Dis
; 13(2): 123-8, 2007 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-17206703
18.
Effects of introduction of an inflammatory bowel disease nurse position on the quality of delivered care.
Eur J Gastroenterol Hepatol
; 29(6): 646-650, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28118176
19.
Vedolizumab Induces Long-term Mucosal Healing in Patients With Crohn's Disease and Ulcerative Colitis.
J Crohns Colitis
; 11(9): 1085-1089, 2017 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28369329
20.
Effects of Education and Information on Vaccination Behavior in Patients with Inflammatory Bowel Disease.
Inflamm Bowel Dis
; 23(2): 318-324, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28079621